BibTex RIS Cite

Sistemik romatizmal hastalıklarda IIF-ANA metoduyla antinükleer antikorlar

Year 2017, Volume: 10 Issue: 3, 234 - 241, 01.10.2017

Abstract

Amaç:Antinükleer antikor, sistemik romatizmal hastalıkların tanı ve tedavisinde yıllardır kullanılmaktadır.
İndirekt immünfloresan (IIF) yöntem antinükleer antikor (ANA) varlığını tespit etmede altın standart yöntemdir.
Bu çalışmanın amacı sistemik romatizmal hastalıklarda ANA boyanma tipleri, titrasyon ve antikor tiplerinin
ilişkisini araştırmaktır.
Gereç ve yöntem:Çalışmaya Eylül-Aralık 2015 tarihleri arasında kliniğimize başvuran, ANA sonucu pozitif olup
subgrup analizi yapılmış olan, yeni sistemik romatizmal hastalık tanısı konulmuş toplam 215 hasta dahil edildi.
ANA, IIF yöntemiyle, ANA subgrupları immünblot yöntemi ile ticari kitler kullanılarak çalışıldı. ANA boyanma
tipleri, titrasyon ve antikor tipleri, sistemik romatizmal hastalık tipleri ile karşılaştırıldı.
Bulgular:Çalışmamızda en sık ANA boyanma tipi granüler (%34.3) ve homojen (%33.5) özellikte olup, antikor
analizinde en sık R0-52 (%28.8), SS-A (%24.1) ve ds-DNA (%19.06) pozitifliği saptandı. ANA titrasyonu, sıklık
sırasına göre 1/100, 1/320, 1/1000 ve üstü şeklinde idi.
Sonuç:Spesifik antikor pozitifliklerinin en sık sistemik lupus eritematozus ve sistemik skleroderma’da
görülmesine rağmen, değişen oranlarda tüm sistemik romatizmal hastalıklarda saptanması, tanı ve izlemde
ANA’nın klinikle birlikte değerlendirilmesi gerektiğinin önemini göstermektedir.

Antinuclear antibodies by IIF-ANA method in systemic rheumatic diseases

Year 2017, Volume: 10 Issue: 3, 234 - 241, 01.10.2017

Abstract

Purpose:Antinuclear antibodies have been used for years for diagnosis and follow-up of systemic rheumatic
diseases. Indirect immunofluorescence assay (IIF) is the gold standard to reveal the presence of ANA (ANA).
This study intends to investigate by the IF-ANA method the relation of ANA staining patterns, titration and
antibodies types with systemic rheumatic diseases.
Materials and methods:The study included 215 patients, who were being followed up in our clinic with the
diagnosis of systemic rheumatic disease between September 2015 and December 2015, who had an ANApositive
test and underwent subgroup analysis. ANA was tested using IIF method and ANA profile was tested
by using a commercial kit with immunoblotting. ANA staining patterns, titration results, and results of antibodies
types were compared with types of systemic rheumatic disease.
Results:In the study, the most frequent ANA staining pattern was granular (34.4%) and homogeneous (33.5%)
while the most frequent result in the subgroup analysis was R0-52 (28.8%), SS-A (24.1%), and ds-DNA (19.06%)
positive. The most frequent ANA titration was 1/100, 1/320, 1/1000 and above, respectively.
Conclusion:Although specific antibody positivity is higher in SLE and SSc, the existence of specific antibodies
in different percentages in all the rheumatic diseases indicates the importance of using ANA with the clinic
findings in the diagnosis and follow-up of systemic rheumatic disease.

There are 0 citations in total.

Details

Other ID JA57RC64JV
Journal Section Research Article
Authors

Songül Çildağ This is me

Berna Korkmazgil This is me

Yasemin Kara This is me

Hacer Kale This is me

Nesim Akın This is me

Taşkın Şentürk This is me

Publication Date October 1, 2017
Submission Date October 1, 2017
Published in Issue Year 2017 Volume: 10 Issue: 3

Cite

APA Çildağ, S., Korkmazgil, B., Kara, Y., Kale, H., et al. (2017). Antinuclear antibodies by IIF-ANA method in systemic rheumatic diseases. Pamukkale Medical Journal, 10(3), 234-241.
AMA Çildağ S, Korkmazgil B, Kara Y, Kale H, Akın N, Şentürk T. Antinuclear antibodies by IIF-ANA method in systemic rheumatic diseases. Pam Med J. October 2017;10(3):234-241.
Chicago Çildağ, Songül, Berna Korkmazgil, Yasemin Kara, Hacer Kale, Nesim Akın, and Taşkın Şentürk. “Antinuclear Antibodies by IIF-ANA Method in Systemic Rheumatic Diseases”. Pamukkale Medical Journal 10, no. 3 (October 2017): 234-41.
EndNote Çildağ S, Korkmazgil B, Kara Y, Kale H, Akın N, Şentürk T (October 1, 2017) Antinuclear antibodies by IIF-ANA method in systemic rheumatic diseases. Pamukkale Medical Journal 10 3 234–241.
IEEE S. Çildağ, B. Korkmazgil, Y. Kara, H. Kale, N. Akın, and T. Şentürk, “Antinuclear antibodies by IIF-ANA method in systemic rheumatic diseases”, Pam Med J, vol. 10, no. 3, pp. 234–241, 2017.
ISNAD Çildağ, Songül et al. “Antinuclear Antibodies by IIF-ANA Method in Systemic Rheumatic Diseases”. Pamukkale Medical Journal 10/3 (October 2017), 234-241.
JAMA Çildağ S, Korkmazgil B, Kara Y, Kale H, Akın N, Şentürk T. Antinuclear antibodies by IIF-ANA method in systemic rheumatic diseases. Pam Med J. 2017;10:234–241.
MLA Çildağ, Songül et al. “Antinuclear Antibodies by IIF-ANA Method in Systemic Rheumatic Diseases”. Pamukkale Medical Journal, vol. 10, no. 3, 2017, pp. 234-41.
Vancouver Çildağ S, Korkmazgil B, Kara Y, Kale H, Akın N, Şentürk T. Antinuclear antibodies by IIF-ANA method in systemic rheumatic diseases. Pam Med J. 2017;10(3):234-41.

Creative Commons Lisansı
Pamukkale Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License